Bascoul-Mollevi C - Search Results

1

Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons.

Pouget JP, Santoro L, Raymond L, Chouin N, Bardiès M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pèlegrin M, Vivès E, Pèlegrin A. Pouget JP, et al. Radiat Res. 2008 Aug;170(2):192-200. doi: 10.1667/RR1359.1. Radiat Res. 2008. PMID: 18666820

2

Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.

Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M, Navarro-Teulon I, Pèlegrin A, Pouget JP. Santoro L, et al. J Nucl Med. 2009 Dec;50(12):2033-41. doi: 10.2967/jnumed.109.066993. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910417 Free PMC article.

3

Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.

Boudousq V, Ricaud S, Garambois V, Bascoul-Mollevi C, Boutaleb S, Busson M, Quenet F, Colombo PE, Bardiès M, Kotzki PO, Navarro-Teulon I, Pèlegrin A, Pouget JP. Boudousq V, et al. J Nucl Med. 2010 Nov;51(11):1748-55. doi: 10.2967/jnumed.110.080226. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956481 Free PMC article.

4

Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane.

Paillas S, Boudousq V, Piron B, Kersual N, Bardiès M, Chouin N, Bascoul-Mollevi C, Arnaud FX, Pèlegrin A, Navarro-Teulon I, Pouget JP. Paillas S, et al. Nucl Med Biol. 2013 May;40(4):471-80. doi: 10.1016/j.nucmedbio.2013.02.001. Epub 2013 Mar 19. Nucl Med Biol. 2013. PMID: 23522976 Free article.

5

DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy.

Piron B, Paillas S, Boudousq V, Pèlegrin A, Bascoul-Mollevi C, Chouin N, Navarro-Teulon I, Pouget JP. Piron B, et al. Nucl Med Biol. 2014 May;41 Suppl:e75-83. doi: 10.1016/j.nucmedbio.2014.01.012. Epub 2014 Feb 6. Nucl Med Biol. 2014. PMID: 24613681 Free article.

6

Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.

Ychou M, Azria D, Menkarios C, Faurous P, Quenet F, Saint-Aubert B, Rouanet P, Pèlegrin M, Bascoul-Mollevi C, Guerreau D, Saccavini JC, Mach JP, Artus JC, Pèlegrin A. Ychou M, et al. Clin Cancer Res. 2008 Jun 1;14(11):3487-93. doi: 10.1158/1078-0432.CCR-07-4698. Clin Cancer Res. 2008. PMID: 18519781 Free PMC article. Clinical Trial.

7

In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.

Larbouret C, Gaborit N, Chardès T, Coelho M, Campigna E, Bascoul-Mollevi C, Mach JP, Azria D, Robert B, Pèlegrin A. Larbouret C, et al. Neoplasia. 2012 Feb;14(2):121-30. doi: 10.1593/neo.111602. Neoplasia. 2012. PMID: 22431920 Free PMC article.

8

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.

Kersual N, Garambois V, Chardès T, Pouget JP, Salhi I, Bascoul-Mollevi C, Bibeau F, Busson M, Vié H, Clémenceau B, Behrens CK, Estupina P, Pèlegrin A, Navarro-Teulon I. Kersual N, et al. MAbs. 2014;6(5):1314-26. doi: 10.4161/mabs.29316. MAbs. 2014. PMID: 25517316 Free PMC article.

9

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.

Ladjemi MZ, Chardes T, Corgnac S, Garambois V, Morisseau S, Robert B, Bascoul-Mollevi C, Ait Arsa I, Jacot W, Pouget JP, Pelegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Breast Cancer Res. 2011 Feb 4;13(1):R17. doi: 10.1186/bcr2826. Breast Cancer Res. 2011. PMID: 21294885 Free PMC article.

10

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.

Larbouret C, Robert B, Bascoul-Mollevi C, Penault-Llorca F, Ho-Pun-Cheung A, Morisseau S, Navarro-Teulon I, Mach JP, Pèlegrin A, Azria D. Larbouret C, et al. Ann Oncol. 2010 Jan;21(1):98-103. doi: 10.1093/annonc/mdp496. Epub 2009 Nov 4. Ann Oncol. 2010. PMID: 19889608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters